PT - JOURNAL ARTICLE AU - Budhiraja, Sandeep AU - Indrayan, Abhaya AU - Aggarwal, Mona AU - Jha, Vinita AU - Jain, Dinesh AU - Tarai, Bansidhar AU - Das, Poonam AU - Aggarwal, Bharat AU - Mishra, RS AU - Bali, Supriya AU - Mahajan, Monica AU - Nangia, Vivek AU - Lall, Ajay AU - Kishore, Nevin AU - Jain, Ashish AU - Singh, Omender AU - Singh, Namrita AU - Kumar, Ashok AU - Saxena, Prashant AU - Dewan, Arun AU - Aggarwal, Ritesh AU - Sahay, Shailesh AU - Dang, Rajiv AU - Mishra, Neelima AU - Mathur, Mohit AU - Chugh, I. M. AU - Aneja, Pankaj AU - Dhall, Sanjay AU - Boobna, Vandana AU - Arora, Vinit AU - Gupta, Ajay AU - Arora, Vijay AU - Mehra, Mukesh AU - Jain, Meenakshi AU - Nakra, Vimal AU - Sharma, BD AU - Pandey, Praveen AU - Singh, YP AU - Vardani, Anil AU - Singal, RK AU - Pandey, Deepak Gargi AU - Bhasin, Atul AU - Nayyar, Sandeep AU - Pande, Rajesh AU - Chaudhary, Pankaj AU - Gupta, Ajay Kr AU - Gupta, Ashish AU - Tayal, Nitesh AU - Gupta, Puneet AU - Gupta, Manish AU - Khetrapal, Sumit AU - Pandove, Sachin AU - Bhasin, Deepak AU - Midha, Devender AU - Singh, Harpal AU - Dixit, Ambrish AU - Sagar, Vinay AU - Chachra, Vaibhav AU - Uniyal, Bhupesh AU - Saxena, Sanjay AU - Singh, Amarjit AU - Sharma, Shalini TI - Differentials in the characteristics of COVID-19 cases in Wave-1 and Wave-2 admitted to a network of hospitals in North India AID - 10.1101/2021.06.24.21259438 DP - 2021 Jan 01 TA - medRxiv PG - 2021.06.24.21259438 4099 - http://medrxiv.org/content/early/2021/06/27/2021.06.24.21259438.short 4100 - http://medrxiv.org/content/early/2021/06/27/2021.06.24.21259438.full AB - Second wave of COVID-19 pandemic in India came with unexpected quick speed and intensity, creating an acute shortage of beds, ventilators, and oxygen at the peak of occurrence. This may have been partly caused by emergence of new variant delta. Clinical experience with the cases admitted to hospitals suggested that it is not merely a steep rise in cases but also possibly the case-profile is different. This study was taken up to investigate the differentials in the characteristics of the cases admitted in the second wave versus those admitted in the first wave.Records of a total of 14398 cases admitted in the first wave (2020) to our network of hospitals in north India and 5454 cases admitted in the second wave (2021) were retrieved, making it the largest study of this kind in India. Their demographic profile, clinical features, management, and outcome was studied.Age-sex distribution of the cases in the second wave was not much different from those admitted in the first wave but the patients with comorbidities and those with greater severity had larger share. Level of inflammatory markers was more adverse. More patients needed oxygen and invasive ventilation. ICU admission rate remained nearly the same. On the positive side, readmissions were lower, and the duration of hospitalization was slightly less. Usage of drugs like remdesivir and IVIG was higher while that of favipiravir and tocilizumab was lower. Steroid and anticoagulant use remained high and almost same during the two waves. More patients had secondary bacterial and fungal infections in Wave-2. Mortality increased by almost 40% in Wave-2, particularly in the younger patients of age less than 45 years. Higher mortality was observed in those admitted in wards, ICU, with or without ventilator support and those who received convalescent plasma.No significant demographic differences in the cases in these two waves, indicates the role of other factors such as delta variant and late admissions in higher severity and more deaths. Comorbidity and higher secondary bacterial and fungal infections may have contributed to increased mortality.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any financial contribution from any funding agency/source.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Institutional Ethics Committee Max Super Speciality Hospital (A unit of Devki Devi Foundation) address : Service Floor Office of Ethics Committee East Block next to Conference Room Max Super Speciality Hospital Saket (A unit of Devki Devi Foundation) 2 Press Enclave Road, Saket, New Delhi 110017 vide ref. no. BHR/RS/MSSH/DDF/SKT-2/IEC/IM/21-15 dated 23rd June2021. The IEC provided no objection and approval for the publication of above manuscript.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the admitted patients data taken from EHR.